The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pure EPA Active Pharmaceutical Ingredient (API) Market Research Report 2025
Synopsis
Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega-3 fatty acid. It is obtained in the human diet by eating oily fish or fish oil, e.g. cod liver, herring, mackerel, salmon, menhaden and sardine, and various types of edible algae. EPA is used as a prescription medicine to reduce triglyceride levels.
This report studies Pure EPA (96.5% purity or higher).
The global Pure EPA Active Pharmaceutical Ingredient (API) market was valued at US$ 307 million in 2023 and is anticipated to reach US$ 604.6 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.
North American market for Pure EPA Active Pharmaceutical Ingredient (API) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pure EPA Active Pharmaceutical Ingredient (API) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pure EPA Active Pharmaceutical Ingredient (API) include KD Pharma, Nippon Suisan Kaisha, Bizen Chemical, AK Biopharm, Maruha Nichiro and Croda Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pure EPA Active Pharmaceutical Ingredient (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pure EPA Active Pharmaceutical Ingredient (API).
Report Scope
The Pure EPA Active Pharmaceutical Ingredient (API) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pure EPA Active Pharmaceutical Ingredient (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pure EPA Active Pharmaceutical Ingredient (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
KD Pharma
Nippon Suisan Kaisha
Bizen Chemical
AK Biopharm
Maruha Nichiro
Croda Pharma
Segment by Type
Purity 96.5%
Purity 99%
Segment by Application
Hypolipidemic Drugs
Cardiovascular Disease Drugs
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pure EPA Active Pharmaceutical Ingredient (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pure EPA Active Pharmaceutical Ingredient (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega-3 fatty acid. It is obtained in the human diet by eating oily fish or fish oil, e.g. cod liver, herring, mackerel, salmon, menhaden and sardine, and various types of edible algae. EPA is used as a prescription medicine to reduce triglyceride levels.
This report studies Pure EPA (96.5% purity or higher).
The global Pure EPA Active Pharmaceutical Ingredient (API) market was valued at US$ 307 million in 2023 and is anticipated to reach US$ 604.6 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.
North American market for Pure EPA Active Pharmaceutical Ingredient (API) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pure EPA Active Pharmaceutical Ingredient (API) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pure EPA Active Pharmaceutical Ingredient (API) include KD Pharma, Nippon Suisan Kaisha, Bizen Chemical, AK Biopharm, Maruha Nichiro and Croda Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pure EPA Active Pharmaceutical Ingredient (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pure EPA Active Pharmaceutical Ingredient (API).
Report Scope
The Pure EPA Active Pharmaceutical Ingredient (API) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pure EPA Active Pharmaceutical Ingredient (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pure EPA Active Pharmaceutical Ingredient (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
KD Pharma
Nippon Suisan Kaisha
Bizen Chemical
AK Biopharm
Maruha Nichiro
Croda Pharma
Segment by Type
Purity 96.5%
Purity 99%
Segment by Application
Hypolipidemic Drugs
Cardiovascular Disease Drugs
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pure EPA Active Pharmaceutical Ingredient (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pure EPA Active Pharmaceutical Ingredient (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pure EPA Active Pharmaceutical Ingredient (API) Market Overview
1.1 Product Overview and Scope of Pure EPA Active Pharmaceutical Ingredient (API)
1.2 Pure EPA Active Pharmaceutical Ingredient (API) Segment by Type
1.2.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Value Comparison by Type (2024-2030)
1.2.2 Purity 96.5%
1.2.3 Purity 99%
1.3 Pure EPA Active Pharmaceutical Ingredient (API) Segment by Application
1.3.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Value by Application: (2024-2030)
1.3.2 Hypolipidemic Drugs
1.3.3 Cardiovascular Disease Drugs
1.4 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Size Estimates and Forecasts
1.4.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue 2019-2030
1.4.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales 2019-2030
1.4.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pure EPA Active Pharmaceutical Ingredient (API) Market Competition by Manufacturers
2.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Average Price by Manufacturers (2019-2024)
2.4 Global Pure EPA Active Pharmaceutical Ingredient (API) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pure EPA Active Pharmaceutical Ingredient (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pure EPA Active Pharmaceutical Ingredient (API), Product Type & Application
2.7 Pure EPA Active Pharmaceutical Ingredient (API) Market Competitive Situation and Trends
2.7.1 Pure EPA Active Pharmaceutical Ingredient (API) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pure EPA Active Pharmaceutical Ingredient (API) Players Market Share by Revenue
2.7.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pure EPA Active Pharmaceutical Ingredient (API) Retrospective Market Scenario by Region
3.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Region: 2019-2030
3.2.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Region: 2019-2024
3.2.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Region: 2025-2030
3.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region: 2019-2030
3.3.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region: 2019-2024
3.3.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region: 2025-2030
3.4 North America Pure EPA Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.4.1 North America Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2030)
3.4.3 North America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pure EPA Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.5.1 Europe Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2030)
3.5.3 Europe Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.6.1 Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2030)
3.6.3 Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Pure EPA Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.7.1 Latin America Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2030)
3.7.3 Latin America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pure EPA Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Type (2019-2030)
4.1.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Type (2019-2024)
4.1.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Type (2025-2030)
4.1.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2019-2030)
4.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Type (2019-2030)
4.2.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Type (2019-2024)
4.2.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Type (2025-2030)
4.2.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2019-2030)
4.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Application (2019-2030)
5.1.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Application (2019-2024)
5.1.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Application (2025-2030)
5.1.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2019-2030)
5.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Application (2019-2030)
5.2.1 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Application (2019-2024)
5.2.2 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Application (2025-2030)
5.2.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2019-2030)
5.3 Global Pure EPA Active Pharmaceutical Ingredient (API) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 KD Pharma
6.1.1 KD Pharma Corporation Information
6.1.2 KD Pharma Description and Business Overview
6.1.3 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product Portfolio
6.1.5 KD Pharma Recent Developments/Updates
6.2 Nippon Suisan Kaisha
6.2.1 Nippon Suisan Kaisha Corporation Information
6.2.2 Nippon Suisan Kaisha Description and Business Overview
6.2.3 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Product Portfolio
6.2.5 Nippon Suisan Kaisha Recent Developments/Updates
6.3 Bizen Chemical
6.3.1 Bizen Chemical Corporation Information
6.3.2 Bizen Chemical Description and Business Overview
6.3.3 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Product Portfolio
6.3.5 Bizen Chemical Recent Developments/Updates
6.4 AK Biopharm
6.4.1 AK Biopharm Corporation Information
6.4.2 AK Biopharm Description and Business Overview
6.4.3 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Product Portfolio
6.4.5 AK Biopharm Recent Developments/Updates
6.5 Maruha Nichiro
6.5.1 Maruha Nichiro Corporation Information
6.5.2 Maruha Nichiro Description and Business Overview
6.5.3 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Product Portfolio
6.5.5 Maruha Nichiro Recent Developments/Updates
6.6 Croda Pharma
6.6.1 Croda Pharma Corporation Information
6.6.2 Croda Pharma Description and Business Overview
6.6.3 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product Portfolio
6.6.5 Croda Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pure EPA Active Pharmaceutical Ingredient (API) Industry Chain Analysis
7.2 Pure EPA Active Pharmaceutical Ingredient (API) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pure EPA Active Pharmaceutical Ingredient (API) Production Mode & Process
7.4 Pure EPA Active Pharmaceutical Ingredient (API) Sales and Marketing
7.4.1 Pure EPA Active Pharmaceutical Ingredient (API) Sales Channels
7.4.2 Pure EPA Active Pharmaceutical Ingredient (API) Distributors
7.5 Pure EPA Active Pharmaceutical Ingredient (API) Customers
8 Pure EPA Active Pharmaceutical Ingredient (API) Market Dynamics
8.1 Pure EPA Active Pharmaceutical Ingredient (API) Industry Trends
8.2 Pure EPA Active Pharmaceutical Ingredient (API) Market Drivers
8.3 Pure EPA Active Pharmaceutical Ingredient (API) Market Challenges
8.4 Pure EPA Active Pharmaceutical Ingredient (API) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pure EPA Active Pharmaceutical Ingredient (API) Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pure EPA Active Pharmaceutical Ingredient (API), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pure EPA Active Pharmaceutical Ingredient (API), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pure EPA Active Pharmaceutical Ingredient (API), Product Type & Application
Table 12. Global Key Manufacturers of Pure EPA Active Pharmaceutical Ingredient (API), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pure EPA Active Pharmaceutical Ingredient (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pure EPA Active Pharmaceutical Ingredient (API) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Region (2019-2024) & (Tons)
Table 18. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2019-2024)
Table 19. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales by Region (2025-2030) & (Tons)
Table 20. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2025-2030)
Table 21. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2019-2024)
Table 23. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2025-2030)
Table 25. North America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2024) & (Tons)
Table 27. North America Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2025-2030) & (Tons)
Table 28. North America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2024) & (Tons)
Table 32. Europe Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2025-2030) & (Tons)
Table 33. Europe Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons) by Type (2019-2024)
Table 51. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons) by Type (2025-2030)
Table 52. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2019-2024)
Table 53. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2025-2030)
Table 54. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2019-2024)
Table 57. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2025-2030)
Table 58. Global Pure EPA Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Type (2019-2024)
Table 59. Global Pure EPA Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Type (2025-2030)
Table 60. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons) by Application (2019-2024)
Table 61. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons) by Application (2025-2030)
Table 62. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2019-2024)
Table 63. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2025-2030)
Table 64. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2019-2024)
Table 67. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2025-2030)
Table 68. Global Pure EPA Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Application (2019-2024)
Table 69. Global Pure EPA Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Application (2025-2030)
Table 70. KD Pharma Corporation Information
Table 71. KD Pharma Description and Business Overview
Table 72. KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. KD Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product
Table 74. KD Pharma Recent Developments/Updates
Table 75. Nippon Suisan Kaisha Corporation Information
Table 76. Nippon Suisan Kaisha Description and Business Overview
Table 77. Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Nippon Suisan Kaisha Pure EPA Active Pharmaceutical Ingredient (API) Product
Table 79. Nippon Suisan Kaisha Recent Developments/Updates
Table 80. Bizen Chemical Corporation Information
Table 81. Bizen Chemical Description and Business Overview
Table 82. Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Bizen Chemical Pure EPA Active Pharmaceutical Ingredient (API) Product
Table 84. Bizen Chemical Recent Developments/Updates
Table 85. AK Biopharm Corporation Information
Table 86. AK Biopharm Description and Business Overview
Table 87. AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. AK Biopharm Pure EPA Active Pharmaceutical Ingredient (API) Product
Table 89. AK Biopharm Recent Developments/Updates
Table 90. Maruha Nichiro Corporation Information
Table 91. Maruha Nichiro Description and Business Overview
Table 92. Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Maruha Nichiro Pure EPA Active Pharmaceutical Ingredient (API) Product
Table 94. Maruha Nichiro Recent Developments/Updates
Table 95. Croda Pharma Corporation Information
Table 96. Croda Pharma Description and Business Overview
Table 97. Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Croda Pharma Pure EPA Active Pharmaceutical Ingredient (API) Product
Table 99. Croda Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Pure EPA Active Pharmaceutical Ingredient (API) Distributors List
Table 103. Pure EPA Active Pharmaceutical Ingredient (API) Customers List
Table 104. Pure EPA Active Pharmaceutical Ingredient (API) Market Trends
Table 105. Pure EPA Active Pharmaceutical Ingredient (API) Market Drivers
Table 106. Pure EPA Active Pharmaceutical Ingredient (API) Market Challenges
Table 107. Pure EPA Active Pharmaceutical Ingredient (API) Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pure EPA Active Pharmaceutical Ingredient (API)
Figure 2. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Share by Type in 2023 & 2030
Figure 4. Purity 96.5% Product Picture
Figure 5. Purity 99% Product Picture
Figure 6. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Share by Application in 2023 & 2030
Figure 8. Hypolipidemic Drugs
Figure 9. Cardiovascular Disease Drugs
Figure 10. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pure EPA Active Pharmaceutical Ingredient (API) Sales (2019-2030) & (Tons)
Figure 13. Global Pure EPA Active Pharmaceutical Ingredient (API) Average Price (US$/Kg) & (2019-2030)
Figure 14. Pure EPA Active Pharmaceutical Ingredient (API) Report Years Considered
Figure 15. Pure EPA Active Pharmaceutical Ingredient (API) Sales Share by Manufacturers in 2023
Figure 16. Global Pure EPA Active Pharmaceutical Ingredient (API) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Pure EPA Active Pharmaceutical Ingredient (API) Players: Market Share by Revenue in 2023
Figure 18. Pure EPA Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Pure EPA Active Pharmaceutical Ingredient (API) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2019-2030)
Figure 21. North America Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2019-2030)
Figure 22. United States Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2019-2030)
Figure 25. Europe Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2019-2030)
Figure 33. China Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2019-2030)
Figure 41. Latin America Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Pure EPA Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Pure EPA Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Pure EPA Active Pharmaceutical Ingredient (API) by Type (2019-2030)
Figure 52. Global Revenue Market Share of Pure EPA Active Pharmaceutical Ingredient (API) by Type (2019-2030)
Figure 53. Global Pure EPA Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Type (2019-2030)
Figure 54. Global Sales Market Share of Pure EPA Active Pharmaceutical Ingredient (API) by Application (2019-2030)
Figure 55. Global Revenue Market Share of Pure EPA Active Pharmaceutical Ingredient (API) by Application (2019-2030)
Figure 56. Global Pure EPA Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Application (2019-2030)
Figure 57. Pure EPA Active Pharmaceutical Ingredient (API) Value Chain
Figure 58. Pure EPA Active Pharmaceutical Ingredient (API) Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
